People: ANI Pharmaceuticals Inc (ANIP.OQ)
Mr. Arthur S. Przybyl is President, Chief Executive Officer, Director of the Company. Mr. Przybyl is an experienced healthcare executive in a career that spans over 25 years and includes the management of both specialty pharmaceutical and medical device companies. From August 2002 through January 2009, Mr. Przybyl served as President and Chief Executive Officer of Akorn, Inc., a NASDAQ-listed specialty pharmaceutical company that manufactures and markets ophthalmic, liquid and lyophilized injectable, and vaccine drug products. Prior to Akorn, Mr. Przybyl was President of privately-held company Hearing Innovations, Inc. and President and Chief Operating Officer of NASDAQ-listed company Bioject, Inc., both of which are medical device companies. During his career, Mr. Przybyl has held several sales and marketing management positions, including Senior Vice President, Sales and Marketing for International Medication Systems, Inc. and Director, Corporate Marketing and National Accounts for LyphoMed, Inc., both specialty pharmaceutical companies.
|Total Annual Compensation, USD||1,401,920|
|Restricted Stock Award, USD||1,660,450|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,135,560|
|Fiscal Year Total, USD||4,197,930|